In light of that, it is perhaps paradoxical that the level of TGF-β is not reduced in MCI [70], but the level of FAMC in AD, a key molecule in the formation of TGF-β, is reduced by ~30–50% [70,71]. This evidence concerns the gene TGFB1 and Alzheimer disease.